S. Minatoguchi et al., EFFECTS OF ADRENALINE INFUSION ON PLASMA-LIPIDS AND NORADRENALINE LEVELS IN RABBITS WITH ADRIAMYCIN-INDUCED CARDIOMYOPATHY, Clinical and experimental pharmacology and physiology, 24(7), 1997, pp. 477-480
1. We investigated the acute effects of adrenaline infusion on plasma
lipid levels in vehicle- and adriamycin-treated rabbits, Lipids were m
easured before and 30 and 60 min after the commencement of continuous
intravenous administration of adrenaline (0.06 mu g/kg per min) or sal
ine in pentobarbital-anaesthetized rabbits. 2. Adrenaline infusion sig
nificantly increased plasma free fatty acid (P < 0.05) and noradrenali
ne (NA) levels (P < 0.05) in vehicle-treated control rabbits, but not
in adriamycin-treated rabbits. However, adrenaline had no effect on pl
asma total cholesterol, free cholesterol, high-density lipoprotein-cho
lesterol, triglyceride or phospholipid levels. 3. Pretreatment with pr
opranolol almost completely inhibited increased plasma free fatty acid
and NA levels associated with adrenaline infusion, suggesting that ad
renaline increases plasma free fatty acid and NA levels via the stimul
ation of beta-adrenoceptors in vehicle-treated rabbits. 4. It is sugge
sted that both the production of plasma free fatty acids and the relea
se of NA via the activation of beta-adrenoceptors is reduced in rabbit
s with adriamycin-induced cardiomyopathy. This may be related to the d
own-regulation of beta-adrenoceptors caused by elevated plasma NA leve
ls induced by cardiac failure.